BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 2010186
CINCINNATI, OH
Position in DNLI
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$38,580
+$9,780 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#218
of 293 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,629,105 across 20 Biotechnology names. DNLI ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $605,394 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
4,144 | $324,350 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
575 | $285,619 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363 | $226,345 | |
| 5 | INCY |
Incyte Corp
|
363 | $41,149 | |
| 6 | DNLI |
Denali Therapeutics Inc.
This page
|
1,500 | $38,580 | |
| 7 | CADL |
Candel Therapeutics, Inc.
|
3,520 | $36,256 | |
| 8 | GUTS |
Fractyl Health, Inc.
|
25,000 | $19,850 |
All Filings in DNLI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,580 | 1,500 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $28,800 | 1,500 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $24,765 | 1,500 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $21,780 | 1,500 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $20,985 | 1,500 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $20,392 | 1,500 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $30,570 | 1,500 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $43,695 | 1,500 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $34,830 | 1,500 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $30,780 | 1,500 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $32,190 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $511,624 | 24,800 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $635,645 | 21,540 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $496,281 | 21,540 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $577,891 | 20,780 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $637,738 | 20,780 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $544,778 | 18,511 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $595,466 | 18,510 | Shares | Sole | 2024-02-14 | |
| 2021-12-31 | $755,657 | 16,943 | Shares | Sole | 2024-02-14 | |
| 2021-09-30 | $75,675 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $117,660 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2021-03-31 | $85,650 | 1,500 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $167,520 | 2,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||